top of page
  • Writer's pictureEVOCAL Health

Vocal Biomarkers in Cardiac Rhythm Management and Remote Patient Monitoring

EVOCAL Health discusses scientific findings with industry-leaders

©m:con/Ben van Skyhawk

Mannheim/Hamburg (Germany), April 21, 2022: The 88th Annual Meeting of the German Society of Cardiology (Deutsche Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V., “DGK”) in Mannheim was the first major medical congress held locally since the beginning of the pandemic: 5,000 cardiologists from Germany, Austria, and Switzerland gathered in the Congress Center Rosengarten in Mannheim for four days to discuss developments and research in the field of cardiology, and exchange ideas in scientific symposia.

EVOCAL Health representatives were also present to discuss industry partnerships and the latest scientific findings in the field of cardiac rhythm management and opportunities for non-invasive remote patient monitoring using the human voice as a biomarker for cardiovascular health. A central theme is the development of a national strategy to combat cardiovascular disease, said Stephan Baldus, president of the German Society of Cardiology. Therefore, much of the discussion revolved around the question of how to improve therapy outcomes through greater digitization, greater networking, and more outpatient treatments.

Recently, a meta-analysis conducted by American scientists attracted attention in cardiovascular medicine: The analysis revealed that compared with the standard of care among patients with heart failure, digital health interventions provided a significant reduction in all-cause mortality and cardiovascular mortality, and contributed to fewer total days lost to HF hospitalizations.

EVOCAL Health Co-Founder Dirk Simon: “Evidence is mounting that digital interventions improve heart failure mortality. Patients supported with remote telemonitoring devices, telehealth consultations, and remote rehabilitation show significantly better therapy outcomes in heart failure. Digital technologies have now arrived: At the top of the agenda of congresses, but more importantly where we need them the most: In the hands of the patient.”

bottom of page